Curaleaf Stock Surges Nearly 10% on CBD Study Breakthrough

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-08-22 03:39:01

BTCCSquare news:

Curaleaf shares soared nearly 10% Thursday after researchers uncovered potential new therapeutic applications for cannabidiol. A University of California study funded by the National Institute on Alcohol Abuse and Alcoholism demonstrated CBD's efficacy in reducing withdrawal symptoms and relapse rates in rodent models of alcoholism.

The findings, published in Nature, mark a significant development for non-psychoactive cannabis compounds. Federal involvement in the research suggests growing institutional recognition of CBD's medical potential, though the study remains in preclinical stages. Market reaction highlights investor enthusiasm for cannabis stocks with legitimate therapeutic pipelines.

By:

Log in to Reply

VeBetterDAO Launches Uranus GM NFTs to Boost User Engagement and Governance

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.